-
Barcelona hit seven in Racing Santander rout
-
US Fed raises rates to tackle 'too high' inflation, irking Trump
-
Amorim's Milan beaten by Benfica, Sunderland make dream European return
-
Man Utd misery mounts after League Cup collapse against Brighton
-
US stocks fall, dollar gains after Fed lifts interest rates
-
Turkey releases 106 protesters, jails more LGBTQ activists
-
Seahawks rule out Darnold for Sunday game at Arizona
-
US Fed raises rates to tackle 'too high' inflation in move sure to rile Trump
-
Mbappe explains Ceuta shirt stance after criticism
-
England were 'waiting for death' in World Cup semi-final defeat: Tuchel
-
Improving Atletico cruise to comfortable win over Osasuna
-
NFL star fined for displaying name of slain Palestinian girl
-
Candidate for UN chief calls for AI regulation akin to nuclear weapons
-
Witsel retires from internationals after 18-year Belgium career
-
O'Neill expects Celtic recovery after Old Firm misery
-
US Fed raises rates to battle inflation in move likely to rile Trump
-
Man City midfield trio backed to emulate Rodri and Silva
-
Fitzpatrick 'not comfortable' over Dubai golf finale
-
'We're losing control,' AI pioneer Yoshua Bengio tells AFP
-
Gaza apartment block collapse kills 21, including 12 children
-
WHO eyes 'encouraging' signs in DRCongo fight against Ebola
-
Gaza apartment block collapse leaves 21 dead
-
Liga boss criticises Real Madrid trio for Ceuta shirt incident
-
US House targets data centers as midterm backlash grows
-
WTA Finals moved to Charlotte from 2027
-
French ex-minister Dati goes on trial in Renault-Nissan corruption case
-
Almost 8,000 excess deaths in France's scorched summer: statistics
-
'Being Heumann' captures joy in fight for disability rights
-
Ex-president's lengthy war crimes sentence shocks Kosovo
-
Retired great Nadal to play in exhibition matches
-
US House faces test on sweeping Russia sanctions bill
-
IR-MED and Dice Technologies Announce collaboration to Evaluate and Advance Pressure-Injury Prevention Platform in Japan
-
British PM says to make 'difficult decisions' as inflation rises
-
Watts, Pitt, Cruz to light up Spain's top film festival
-
TotalEnergies pumps up controversy in France with cut-price gas
-
Sweden expels Iran embassy employee over anti-Jewish threats
-
Global fuel price demos: a round-up
-
Toogood Gold's Table Mountain Sits in the Shadow of a Nevada Gold Rush
-
Leverate Launches MCP for Traders to Connect AI Assistants With Trading Platforms
-
MEXC July–August Security Report: 38.66M USDT in Risk Funds Intercepted, Futures Insurance Fund Hits 792M USDT
-
MEXC Launches $1M "Discover Your Wall Street DNA" Campaign to Help Traders Find Their Market Fit
-
'Breathing toxin every day': Indonesians choked by haze feel helpless
-
Emporio Armani names Dario Vitale new creative director
-
Stocks edge higher ahead of US Fed rate call
-
Maresca defends VAR officials after Man City benefit from error
-
Philippines ex-leader Duterte makes first in-person ICC appearance
-
Courts jails LGBTQ activists as Turkey crackdown widens
-
2027 Formula One calendar includes Monaco sprint race
-
French court to hear Depardieu's appeal against rape trial order: sources
-
Palestinians are the real victims, Thunberg tells Ed Sheeran
Germany's homegrown cannabis industry awaits legalisation
In the east German countryside, close to Dresden, a former abattoir is now home to the biggest indoor cannabis farm in Europe.
Behind the recently renovated concrete walls, the German startup Demecan has been growing marijuana in accordance with the law for the past year.
The company is one of only a handful in Germany to have a license for the production of this "green gold", which has been legal in Germany for medicinal use since 2017.
But the budding industry is eyeing a bigger prize: Chancellor Olaf Scholz's government plans to legalise the drug for recreational use as soon as 2024, which would leave it with one of the most liberal cannabis policies in Europe.
- 'Tenfold' -
Inside the building, the smell of the plants -- lined up in their hundreds under yellow grow lamps -- is overwhelming.
"We will have the option to expand the facility to cultivate recreational cannabis," Demecan's managing director Philipp Goebel tells AFP.
The government coalition, led by Scholz's Social Democrats, has put forward a roadmap for the legalisation of cannabis with a target date of 2024.
Under the draft plans, adults would be allowed to hold a maximum of between "20 and 30 grams" of cannabis for private consumption, via a network of licensed stores and pharmacies.
Demecan's massive complex, which covers around 120,000 square metres (1.3 million square feet), produces one tonne of cannabis a year, but it has yet to reach capacity.
The company could quickly increase production "tenfold" to meet growing demand, Goebel says.
Harvests at the farm happen every two weeks with workers plucking the flowers from the plant stems before they are dried.
"I like this job a lot, it is not like any other," says 34-year-old Sven Skoeries, who studies horticulture alongside his responsibilities at the farm.
Demecan has no trouble recruiting for its growing business, in a region otherwise marked by its ageing population and lack of workers.
"It's a trendy product that generates a lot of interest," Goebel says.
"It's a new industry, that's interesting for me," says Jana Kleinschmidt, 25, as she snips off leaves with a pair of scissors.
As well as its own production efforts, Demecan has a license for the import of another 20 tonnes of cannabis into the country from Canada annually.
"We are currently supplying 55 percent of the German market," says Goebel, who notes his firm is in "pole position" to capitalise on legalisation.
- Snoop Dogg -
The recreational cannabis market in Germany is a potential four-billion-euro ($4.2 billion) business, according to a recent study by the Heinrich Heine University in Duesseldorf.
In recent months, fundraising in the sector has taken off as businesses await the green light from legislators.
Berlin startup Cantourage, a manufacturer of cannabis-based medicines, floated 15 percent of its shares on the Frankfurt stock exchange in November.
Cansativa, the only online platform for the sale of therapeutic cannabis products in Germany, raised $15 million in February with the help of US rapper Snoop Dogg.
Sanity Group, a German company that focuses on cannabis-derived products, likewise raised $37.6 million in September.
Legalisation looks like a good deal for the government, too. The same study from Heinrich Heine University estimated the move would boost the public finances by 4.7 billion euros per year.
But the idea remains controversial.
At the end of October, Klaus Reinhardt, the head of the German Medical Association, called the plans "almost cynical".
It was "shocking" to legalise a substance that could "lead to behavioural problems in adolescents, as well as addiction and psychological changes", he said.
The conservative opposition to the government has also set itself against the move.
The Bavarian state Health Minister Klaus Holetschek, who is part of the conservative Christian Social Union party, called the idea "a dangerous signal for all of Europe".
First, however, the government's plans need to be approved by the European Commission -- or they risk going up in smoke.
R.Chavez--AT